News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

Generative AI Is Upending Freelance Work – Even Top Performers Aren’t Safe
News Release

BALTIMORE, MD, March 4, 2025 – A groundbreaking study has uncovered a startling reality: generative AI tools like ChatGPT are already reshaping the freelance job market, slashing employment opportunities and pay for workers across all skill levels. Even top freelancers – those with the strongest track records – are suffering the greatest setbacks.

Read More
The 3 biggest things to know about a potential U.S.-Ukraine minerals deal
Media Coverage

Contentious minerals deal has sparked a war of words between Trump and Zelensky, and could be announced later this week

Read More
How tariffs can hurt American supply chains | GUEST COMMENTARY
Media Coverage

Americans have probably heard the word “tariffs” more in the past month than in the past four years — and for good reason. Tariffs are central to President Donald Trump’s economic playbook, despite opposition from mainstream economists and trade experts

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Why We Need A Blue-Collar AI Workforce

Why We Need A Blue-Collar AI Workforce

Forbes, April 1, 2021

The 2020 LinkedIn U.S. Emerging Jobs Reportidentified the top 15 jobs over the previous five years and emphasized that “artificial intelligence and data science roles continue to proliferate across nearly every industry.” Artificial intelligence specialist (No. 1) showed 74% annual growth, and data scientist (No. 3) and data engineer (No. 8) followed with 37% and 33% annual growth.

Walgreens not following U.S. guidance on Pfizer vaccine spacing

Walgreens not following U.S. guidance on Pfizer vaccine spacing

The Seattle Times, April 5, 2021

Walgreens has inoculated hundreds of thousands of Americans against COVID-19 this year using the vaccine developed by Pfizer and Germany’s BioNTech. But the pharmacy chain has not been following guidance from federal health officials about the timing of second doses.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine